Abstract
α-Tomatine, isolated from Lycopersicon esculentum Linn., is a naturally occurring steroidal glycoalkaloid in immature green tomatoes. Some reports demonstrated that α-tomatine had various anticarcinogenic properties. The purpose of this study is to investigate the anti-metastatic effect of α-tomatine in NCI-H460 human non-small cell lung cancer cells. First, the results showed that α-tomatine significantly suppressed the abilities of the adhesion, invasion, and migration of NCI-H460 cells under non-cytotoxic concentrations. Molecular data also showed α-tomatine could inhibit the activation of focal adhesion kinase (FAK) and phosphatidylinositol 3-kinase (PI3K)/Akt signal involve in the downregulation the enzyme activities, protein and messenger RNA levels of matrix metalloproteinase-7 (MMP-7). Next, α-tomatine also strongly inhibited the degradation of inhibitor of kappaBα (IκBα) and the nuclear levels of nuclear factor kappa B (NF-κB). Also, a dose-dependent inhibition on the binding ability of NF-κB by α-tomatine treatment was further observed. Furthermore, α-tomatine significantly decreased the levels of phospho-Akt and MMP-7 in Akt1-cDNA-transfected cells concomitantly with a marked reduction on cell invasion and migration. Presented results indicated α-tomatine might be further application for treating cancer metastasis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Lung cancer is one of the most common types of cancer in the world, and accounts for around more than a million deaths yearly worldwide. This high mortality of probably attributable to early metastasis, principally through the spreading of malignant cells, especially non-small cell lung carcinoma (NSCLC) [1], to distant organs such as the brain, contralateral lung, and bone as a result of the hematogenous spread of cancer cells [2, 3]. Also, non-small cell lung cancers commonly develop resistance to radiation and chemotherapy, and often present at stages too late for surgical intervention. Thus, effective chemopreventive treatment for metastasis would have an important impact on lung cancer mortality rates.
FAK is a non-receptor tyrosine kinase primarily localized to cell–matrix adhesions which acts as a central regulator of the focal adhesion to influence cell survival, differentiation, proliferation, metastasis, and tissue remodeling [4–6]. Tumor metastasis occurs by a series of steps and various cytophysiological changes, including damaged intercellular interaction, increased cancer cells and extracellular matrix (ECM) interaction, damaged ECM components, vessel formation. Excess ECM degradation is one of the hallmarks of tumor invasion and migration, and is regulated by extremely complicated mechanisms [7]. PI3K/Akt signal transduction pathway was found to be necessary to mediate the proliferation and metastasis of human non-small cell lung cancer (NSCLC) and is closely associated with the development and progress of various tumors [8]. Akt kinase, an important component of postsurvival signaling pathways, is activated via PI3K signaling pathway. [9]. The mitogen-activated protein kinases surperfamily members (MAPK) are associated with increased scattering/motility, invasion, proliferation, survival, and morphogenesis [10, 11]. Three major mammalian MAP kinases include extracellular signal-regulated kinase1 and 2 (ERK1/2), c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK), and p38 MAPK. The diverse MAP kinase members are activated in response to different extracellular stimuli and have distinct downstream targets, thus serving different roles in cellular responses. ERK1/2, p38 MAPK, and JNK/SAPK play a central role in regulating the expressions of MMPs [12–14]. The promoter of MMPs is highly conserved and shown to contain multiple functional elements, including NF-κB, AP-1, and EST elements [15, 16].
Many NF-κB activation pathways have been revealed, and all of them rely upon sequentially activated kinase cascades [17]. NF-κB is a multisubunit transcription factor, which is involved in immune response, inflammation, and malignant transformation. The active NF-κB consists of p50, p52, p65 (Rel A), Rel B, and c-Rel. Under normal condition, NF-κB is maintained in the cytoplasm through interactions with an inhibitor of NF-κB (IκB), but upon dissociation, moves into the nucleus and promotes cancer cells proliferation, angiogenesis, and metastasis [18, 19]. AP-1 is a nuclear transcription, which is involved in cell proliferation, differentiation, apoptosis, and neoplastic transformation. AP-1 consists of homodimers and heterodimers of members from Fos (c-Fos, Fos B, Fra-1, and Fra-2) and Jun (c-Jun, Jun B, and Jun D) families [20].
α-Tomatine occurs naturally in tomatoes (Lycopersicon esculentum). Immature green tomatoes contain up to 500 mg α-tomatine/kg fresh fruit weight. The compound is partly degraded as the tomato ripens until at maturity levels in red tomatoes are about 5 mg/kg fresh fruit weight [21]. Figure 1a shows α-tomatine is constructed of an aglycon moiety (tomatidine), and a tetrasaccharide moiety (β-lycotetrose) that contains two molecules of d-glucose and one each of d-galactose and d-xylose. Previous studies demonstrated α-tomatine has exhibited antiproliferative and apoptotic effects on the growth of cancer cells originating from the human colon and liver [22]. In addition, α-tomatine also induced T-cell-mediated regression of murine lymphoid experimental tumors, EG7-Ova [23], and acted as an anti-inflammatory agent by blocking NF-κB and JNK signaling in mouse macrophages [24]. In this study, we employed human non-small cell lung cancer NCI-H460 cells to assess the molecular mechanism responsible for the antimetastatic effect of α-tomatine. We found that α-tomatine suppresses invasion and migration of NCI-H460 cells through inactivating PI3K/Akt signaling pathway.
Materials and Methods
Test Compound
α-Tomatine purchased from Extrasynthese (Genay, France), dissolved in dimethyl sulfoxide (DMSO) and stored at −20°C. The purity was >98%, as assessed by HPLC. Control cultures received the carrier solvent (0.1% DMSO).
Cell Culture
Non-small-cell lung cancer cell line NCI-H460 (human lung large cell carcinoma) was maintained in RPMI-1640 medium. Normal lung cell line WI-38 (human lung epithelial fibroblast) was maintained in MEM medium. Above-mentioned cell lines were obtained from BCRC (Bioresource Collection and Research Center in Hsin-Chu, Taiwan). All cells were cultured at 37°C in a humidified atmosphere of 5% CO2–95% air. In medium supplemented with 10% fetal calf serum, 2 mM l-glutamine, 1 mM sodium pyruvate, and antibiotics (100 U/ml of penicillin and 100 mg/ml of streptomycin).
Cell Viability Assay
To measure the effect of α-tomatine on cell viability, the NCI-H460 and WI-38 cells (1 × 105 cells/ml) were seeded into a 24-well plate. Cells were treated with or without α-tomatine under various concentrations for various periods of time (24 and 48 h). At the end of the assay period, cell viability was measured by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide] assay, as described previously [25]. Each concentration was repeated three times. After the exposure period, the medium was removed and followed by washing the cells with PBS. Then, the medium was changed and incubated with MTT solution (5 mg/ml)/well for 4 h. The medium was removed, and formazan was solubilized in isopropanol and measured spectrophotometrically at 563 nm. The percentage of viable cells was estimated by comparing with the untreated control cells.
Cell-Cycle Assay
Flow cytometric analysis of NCI-H460 cells was performed using a FACScan (Becton Dickinson Immunocytometry Systems, UK). To analyze the cell-cycle distribution, the cells were first treated with various concentrations of α-tomatine for 24 h, and then were collected by trypsinization, fixed in 75% absolute ethanol, washed in PBS, resuspended in 1 ml of PBS containing 0.5 mg/ml ribonuclease (RNase) A and 0.01 mg/ml propidium iodide (PI) in the dark for 30 min at room temperature. The cell-cycle profiles were analyzed by a flow cytometer. The percentage of cell in the sub-G1, G0/G1, S, and G2/M phases of the cell cycle was analyzed by the ModFit LT 3.0 software (Verity Software, Topsham, ME).
Mitochondrial Membrane Potential Assay
We used mitochondrial-specific cationic dye JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-benzimidazolycarbocyanine iodide) (Molecular Probes, Inc.), which undergoes potential-dependent accumulation in the mitochondria. Cells were seeded in a 96-well plate. Following treatment with α-tomatine (0, 1.5, 3, and 4 μM) for the indicated times, cells were stained with 25 μM JC-1 for 30 min at 37°C. Fluorescence was monitored with the fluorescence plate reader at wavelengths of 490 nm (excitation)/540 nm (emission) and 540 nm (excitation)/590 nm (emission) pairs. Changes in the ratio between the measurement at test wavelengths of 590 nm (red) and 540 nm (green) fluorescence intensities are indicative of changes in the mitochondrial membrane potential.
Measurement of Intracellular ROS Formation
Intracellular ROS was estimated using a fluorescent probe, 2′,7′-dichlorofluorescein diacetate (DCFH-DA). DCFH-DA diffuses through the cell membrane readily and is enzymatically hydrolyzed by intracellular esterases to non-fluorescent dichlorofluorescin (DCFH), which is then rapidly oxidized to highly fluorescent DCF in the presence of ROS. Following exposure to various concentrations of α-tomatine, NCI-H460 cells (1 × 105 cells/ml) were incubated in a culture medium containing 20 μM DCFH-DA for 30 min at 37°C, and then were washed with PBS. The cell suspensions were centrifuged at 412×g for 10 min and medium was removed. Cells were dissolved with 1% Triton X-100, and DCF fluorescence intensity was detected at different time intervals with excitation wavelength 503 nm and emission wavelength at 529 nm (slit width: 5 nm). The DCF fluorescence intensity is proportional to the amount of ROS formed intracellularly [26].
Measurement of Intracellular GSH Content
Intracellular levels of GSH were determined using the method of Hisin and Hilf [27]. Cells after treatment were washed with PBS and scrapped into 6.5% trichloroacetic acid. Phosphate–EDTA buffer (4.5 ml) of pH 8.0 was added to 0.5 ml of 12000×g supernatant. The final assay mixture (2 ml) contained 100 μl of the diluted supernatant, 1.8 ml phosphate–EDTA buffer pH 8.0, and 100 μl 0.1% o-phthalaldehyde solution containing 100 μg of OPT. After thorough mixing and incubation at room temperature for 15 min fluorescence was read at wavelengths of 350 nm (excitation)/420 nm (emission) in FLUOstar OPTIMA spectrofluorophotometer. The reduced form of GSH was used as a standard. Data were expressed as nanomole GSH per 106 cells.
Cell–Matrix Adhesion Assay
After pretreatment with α-tomatine (0, 0.5, 1, and 1.5 μM) for 24 h, cells were seeded at a density of 1 × 105 cells/ml in a 24-well plate and coated with 500 μl type IV collagen (10 μg/ml); then they were cultured for 30 min. Then, non-adherent cells were removed by PBS washes, and adherent cells were fixed in ethanol. After a staining with 0.1% crystal violet, fixed cells were lysed in 0.2% Triton-100, and measured spectrophotometrically at 550 nm.
Immunofluorescence Staining Assay
To determine the effect of α-tomatine on cell morphology and actin stress fibers, NCI-H460 cells (1 × 105 cells/ml) were plated in six-well plates and grown for 16–18 h and then incubated in the different concentrations of α-tomatine (0, 0.5, 1, and 1.5) for 24 h. After the exposure period, media were removed, and cells were washed with Ca2+/Mg2+ free PBS. Cells were then fixed with 4% paraformaldehyde in Ca2+/Mg2+ free PBS for 15 min and incubated with 0.5% Triton X-100/in Ca2+/Mg2+ free PBS for 5 min. Cells were incubated with 1% bovine serum albumin in 0.5% Triton X-100/in Ca2+/Mg2+ free PBS for 1 h (blocking) and then with 200 units/ml Alexa flour 488-phallodin (Invitrogen, Karlsruhe, Germany) for 1 h to stain the actin filaments. At last, the nucleus were stained with DAPI (1 μg/ml) solution for 30 min at 25°C and examined by a fluorescence microscopy (BX51, Olympus, Tokyo, Japan).
Boyden Chamber Invasion and Migration Assay
The ability of NCI-H460 cells to pass through filters coated with Matrigel (Collaborative Biomedical Products, Bedford, MA) was measured by Boyden chamber invasion assay [28]. Matrigel was diluted to 200 μg/ml with cold filtered distilled water and applied to the top side of the 8 μm pore polycarbonate filter. Briefly, NCI-H460 cells were treated with various concentrations of α-tomatine. After 24 h, cells were detached by trypsin and resuspended in serum-free medium. Medium containing 10% fetal bovine serum medium was applied to the lower chamber as chemoattractant, and then cells were seeded on the upper chamber at a density of 1 × 105 cells/ml in 50 μl of serum-free medium. The chamber was incubated for 8 h at 37°C. At the end of incubation, the cells in the upper surface of the membrane were carefully removed with a cotton swab. Cells invading across the matrigel to the lower surface of the membrane were fixed with methanol and stained with 5% Giemsa solution. The invading cells on the lower surface of the membrane filter were counted with a light microscope. The data are presented as the average number of cells attached to the bottom surface from randomly chosen fields. Each experiment was carried out in triplicate. To measure the ability of NCI-H460 cells on migration, cells were seeded into a Boyden chamber with 8 μm pore polycarbonate filters which were not coated with matrigel. Migrating cells were treated with various concentrations of α-tomatine. The migration assay was measured as described in the invasion assay.
Gelatin- and Casein-Zymography
The activities of MMP-2 and MMP-9 in the conditioned medium were measured by gelatin-zymography assay as described previously [29]. Samples were mixed with loading buffer and electrophoresed on 8% SDS–polyacrylamide gel containing 0.1% gelatin. Electrophoresis was performed at 140 and 110 V for 3 h. Gels were then washed twice in zymography washing buffer (2.5% Triton X-100 in double-distilled H2O) at room temperature to remove SDS, followed by incubation at 37°C for 12–16 h in zymography reaction buffer (40 mM Tris–HCl, 10 mM CaCl2, 0.02% NaN3), stained with Coomassie blue R-250 (0.125% Comassie blue R-250, 0.1% amino black, 50% methanol, 10% acetic acid) for 1 h and destained with destaining solution (20% methanol, 10% acetic acid, 70% double-distilled H2O). Proteolytic activity of MMP-7 was evaluated by β-casein zymography on 12–15% polyacrylamide gels containing 0.1% β-casein as well as by gelatin-zymography.
Western Blotting Analysis
The preparation of cytosolic and nuclear fractions of the cells was performed as described previously [30]. The Western blotting was performed as follows. The denatured samples (50 μg purified protein) were resolved on 10–12% SDS–PAGE gels. The proteins were then transferred onto nitrocellulose membranes. Non-specific binding of the membranes was blocked with Tris-buffered saline (TBS) containing 1% (w/v) non-fat dry milk and 0.1% (v/v) Tween-20 (TBST) for more than 2 h. Membranes were washed with TBST three times for 10 min and incubated with an appropriate dilution of specific primary antibodies in TBST overnight at 4°C. Subsequently, membranes were washed with TBST and incubated with appropriate secondary antibody (horseradish peroxidase-conjugated goat antimouse or antirabbit IgG) for 1 h. After washing the membrane three times for 10 min in TBST, the bands detection were revealed by enhanced chemiluminescence using ECL Western blotting detection reagents and exposed ECL hyperfilm in FUJFILM Las-3000 mini (Tokyo, Japan). Then proteins were quantitatively determined by densitometry using FUJFILM-Multi Gauge V3.0 software.
Reverse Transcriptase Polymerase Chain Reaction (RT–PCR)
Total RNA was extracted by using the total RNA Extraction Midiprep System (Viogene BioTek, Taiwan). Total RNA (2 μg) was transcribed to 20 μl cDNA with 1 μl deoxynucleotide triphosphate (dNTP; dNTP set consists of 2.5 mM aqueous solutions at pH 7.0 of each of dATP, dCTP, dGTP, and dTTP), 1 μl Oligo dT (10 pmol/ml), 1 μl RTase (200 U), 1 μl RNase inhibitor, and 5 × reaction buffer. The appropriate primers (sense of MMP-2, 5′-GGCCCTGTCACTCCTGAGAT-3′, nt 1337-1356; antisense of MMP-2, 5′-GGCATCCAGGTTATCGGGGA-3′, nt 2026-2007; sense of MMP-9, 5′-AGGCCTCTACAGAGTCTTTG-3′, nt 1201-1220; antisense of MMP-9, 5′-CAGTCCAACAAGAAAGGACG-3′, nt 1700-1683; sense of MMP-7, 5′-CTATGCGACTCACCGTGCTG-3′ nt 147-166; antisense of MMP-7, 5′-CTTGAGATAGTCCTGAGCCTGTTC-3′, nt 696-667; sense of GADPH, 5′-CGGAGTCAACGGATTGGTGTT-3′ nt 94-126; antisense of GADPH, 5′-AGCCTTCTCCATGGTTGGTGAAGAC-3′, nt 399-375) were used for polymerase chain reaction (PCR) amplifications. PCR was performed with Platinum Taq polymerase (Invitrogen, San Diego, CA, USA) under the following conditions: 30 cycles of 94°C for 1 min, 59°C (MMP-2 and MMP-7) or 60°C (MMP-9 and GAPDH) for 1 min, 72°C for 1 min followed by 10 min at 72°C. PCR products were analyzed by agarose gel electrophoresis and visualized by treatment with ethidium bromide.
Electrophoretic Mobility Shift Assay (EMSA)
The DNA-binding activities of NF-κB and AP-1 in nuclear extracts were assessed by EMSA [31] using the Lightshift kit from Pierce (Rockford, Illinois, USA) with biotin-labeled double-stranded AP-1 and NF-κB oligonucleotides. A five microgram aliquot of nuclear proteins was mixed with either biotin-labeled NF-κB or AP-1 oligonucleotide probe for 15 min at room temperature or with oligonucleotides containing (sense of NF-κB, 5′-AGTTGAGGGGACTTTCCCAGGC-3′, antisense of NF-κB, 3′-TCAACTCCCCTGAAAGGGTCCG-5; sense of AP-1, 5′-CGCTTGATGACTCAGCCGGAA-3′, antisense of AP-1, 3′-GCGAACTACTGAGTCGGCCTT). DNA probes were added to 10 μl binding reactions containing double-distilled H2O, 5 μg nuclear proteins, 1 μl poly (dI-dC), 1 μl biotin-labeled double-stranded NF-κB oligonucleotides, and 2 μl of 10-fold binding buffer into a microcentrifuge tube and were incubated for 15 min at room temperature. Specific competition binding assays were performed by adding 200-fold excess of unlabeled probe as a specific competitor. Following protein–DNA complexes formation, samples were loaded on a 6% non-denaturing polyacrylamide gel in 0.5 × TBE buffer and then transferred to positively charged nitrocellulose membranes (Millipore, Bedford, MA, USA) and crosslinked in a Stratagene crosslinker. Gel shifts were visualized with streptavidin-horseradish peroxidase followed by chemiluminescent detection.
Transient Transfection with Akt1 cDNA
Transient transfection assay was carried out as described previously [32]. Liposome-mediated transfection was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) on NCI-H460 cells with a control pUSEamp empty vector (as the control group) or an expression construct for Akt1 cDNA in pUSEamp (activated) (Upstate Biotechnology, Lake Placid, NY, USA). Briefly, NCI-H460 cells (2 × 105 cells/well) were plated onto 6-well plates and transfected with the indicated plasmid at 60–70% confluence on the next day using Lipofectamine Plus reagent according to the manufacturer’s instructions. Briefly, lipofectamine (4 μl) and DNA (2 μg) were diluted in 100 μl of RPMI-1640 followed by equilibration at room temperature for 15 min after mixing. The lipofectamine–DNA complex was added to NCI-H460 cells, and incubated for 12 h. Cells were then washed with PBS and replenished with RPMI-1640 containing 20% serum. Twelve hours after transfection, the cells were incubated with 1.5 μM α-tomatine for 24 h. After further 24 h incubation, the media were removed, and cells were washed once with cold PBS. At last, the transfected cells were collected and subjected to Western blot, invasion, and migration assay.
Statistical Analysis
Data were expressed as means ± standard deviation of three independent experiments. Statistical comparisons of the results were made using analysis of variance (ANOVA). Significant differences were established at P ≤ 0.05.
Results
Cytotoxicity of α-Tomatine to NCI-H460 Cells
α-Tomatine is a natural steroidal glycoalkaloid with pleiotropic activities against cancer growth. In this study, we first examined the effect of α-tomatine on cell cytotoxicity in NCI-H460 cells. As shown in Fig. 1b, α-tomatine showed a dose- and time-dependent inhibitory effect on the cell viability of NCI-H460 cells. Compared to 0 μM (DMSO was treated alone, data not shown), after 24 and 48 h treatment with α-tomatine at a concentration between 0 and 1.5 μM was not significantly altered, indicating α-tomatine was not toxic to NCI-H460 cells at these dosages. When cells were treated with 2-4 μM α-tomatine for 24 and 48 h, the cell viability was significantly decreased. These results demonstrated treating with α-tomatine with doses higher than 1.5 μM for 24 and 48 h resulted in dose- and time-dependent loss of cell viability in NCI-H460 cells, but doses lower than 1.5 μM for 24 and 48 h did not cause cytotoxicity. In addition, same procedures were performed on a normal lung cell line WI-38, and result shown that the cytotoxicity effect of α-tomatine on WI-38 cells was not significant when at various concentrations (0–10 μM). In order to ascertain that the dose range was applied in all subsequent experiments to avoid the influence of cell growth and cytotoxicity on the observed parameters, a series of studies were performed to measure the cell growth and cytotoxicity upon α-tomatine stimulation. First, the effects of α-tomatine on NCI-H460 cell-cycle progression were measured by flow cytometry (Fig. 1c). It has revealed that a treatment with 1.5 μM α-tomatine had no effect on the cell-cycle distribution for 24 h. At higher concentrations (2, 2.5, 3, 3.5, and 4 μM), α-tomatine increased the G1 fraction (from 61.53 to 72.31%), and caused an apparent accumulation of the cells in the sub-G1 phase, while decreased the S fraction in a dose-dependent manner (Fig. 1d). Therefore, the results demonstrated that a 24 h treatment of α-tomatine at a concentration ranging from 0 to 1.5 μM had no cytotoxicity to NCI-H460 cells. In addition, α-tomatine had no effect on the mitochondrial membrane potential in the concentration range 0.5–1.5 μΜ, while the NCI-H460 cells were treated with α-tomatine for dramatically reduced mitochondrial membrane potential in a time-dependent manner in the concentration range 3 or 4 μΜ (Fig. 2a). Oxidative reactions in the mitochondria result in the production of reactive oxygen species (ROS), which are converted to H2O2 by superoxide dismutase. The non-enzymatic antioxidant glutathione (γ-glu-cys-gly) is the most abundant weapon against the production of ROS. The depletion of glutathione has been associated with apoptotic cell death machinery [33], as a drop in the GSH levels and concomitant increase in ROS during the apoptosis process has been reported. It has been observed in our studies that there is an increase in the generation of intracellular ROS formation along with decreased levels of GSH in NCI-H460 cells following α-tomatine treatment (2–4 μΜ). While α-tomatine had no effect on the GSH depletion and ROS formation in the concentration range 0.5–1.5 μΜ (Fig. 2b, c). Thus, non-cytotoxic concentrations of α-tomatine (0.5–1.5 μM) were used for subsequent experiments.
α-Tomatine Suppresses the Cell Adhesion, Morphology/Actin Cytoskeleton Arrangement, Invasion, and Migration in NCI-H460 Cells.
Previous studies have demonstrated that the cancer metastasis and invasion are highly related to the degradation of ECM, intercellular adhesion, and cellular motility. First, in the cell–matrix adhesion assay, the result showed the cell adhesion ability of NCI-H460 cells was significantly reduced by a 24 h treatment of α-tomatine. Such reduction was concentration-dependent with a 45% decrease (P < 0.001) when α-tomatine was at 1.5 μM (Fig. 3a). We next assessed the effect of α-tomatine on the cell morphology and actin cytoskeleton arrangement in NCI-H460 cells by immunofluorescence staining assay. The Fig. 3b shows that NCI-H460 cells were treated with 1.5 μM α-tomatine, the cells changed morphology and became elongated, spindle shaped, and shrunken. Furthermore, the effect of α-tomatine on cell invasion and migration were investigated using a Boyden chamber and the results showed α-tomatine induced a dose-dependent decrease in invasion and migration with an increasing concentration of α-tomatine. According to a quantitative assessment, treatment with 1.5 μM of α-tomatine inhibited 74 and 78% of cell invasion and migration after 48 h incubation, respectively, compared with those of the non-α-tomatine-treated group. The rounding form of cells might reduce the invasion and migration ability of cancer cell (Fig. 3c, d). The results demonstrated α-tomatine significantly inhibited the invasion and migration of highly metastatic NCI-H460 cells.
α-Tomatine Suppresses the MMP-7 Activity and Expression in NCI-H460 Cells
As ECM degradation is by overexpression of proteolytic enzyme activity, such as the matrix metalloproteinases. Meanwhile, locomotion of tumor cells into the extracellular matrix and invasion of lymph and blood vessels occur, and the migrated tumor cells concomitantly escape the immunologic system in the circulation, exit to the new tissue, and eventually colonize the distant site [7]. Thus, the effect of α-tomatine on MMPs activities was investigated by gelatin- and casein-zymography under a condition of serum starvation to explain the contribution of MMPs in the inhibitory effect of α-tomatine on the metastatic ability of NCI-H460 cells. As shown in Fig. 4a, treatment with α-tomatine for 24 h dramatically reduced MMP-7 activity in a dose-dependent manner in the concentration range 0.5–1.5 μΜ, while it had no significant effect on MMP-2 and MMP-9 activities. We next used an RT–PCR and Western blot assay to investigate the inhibitory effect of α-tomatine on the mRNA and protein levels of MMPs. The results of RT–PCR and Western blot showed that α-tomatine could reduce the MMP-7 expression. The decrease in mRNA and protein expression was particularly strong when the α-tomatine concentration reached 1.5 μM, but not MMP-2 and MMP-9 (Fig. 4b, c). These results reveal that α-tomatine might regulate MMP-7 expression at transcription level. Furthermore, these results suggested that the antimetastatic effect of α-tomatine was related to the inhibition of enzymatically degradative processes of tumor metastasis.
α-Tomatine Suppresses the FAK/PI3K/Akt Signaling Pathway in NCI-H460 Cells
As we have shown that treatment of α-tomatine to NCI-H460 cells inhibited the cell invasion, migration, and activity of MMP-7, the underlying mechanisms were further investigated by studying the effect of α-tomatine on the constitutive activation status of the three major mammalian MAPKs and Akt. Figure 5 showed the treatment of α-tomatine reduced the phospho-FAK, phospho-Akt and PI3K levels at 6 h after incubation, whereas it had no significant effect on phosphorylated form of p38, JNK1/2, and ERK. Moreover, no significant change in the total amount of Akt, ERK1/2, p38, and JNK1/2 proteins was observed (data not shown).
α-Tomatine Suppresses the DNA-Binding Activity of NF-κB and the Degradation and Phosphorylation of IκBα in NCI-H460 Cells
It was known that the MMP-7 promoter has several transcription factor-response elements, including binding sequences for NF-κB and AP-1 [16, 34]. Also, NF-κB and AP-1 family of transcriptional factors have been known to translocate to the nucleus and regulate the expressions of multiple genes involved in MMP-7 secretion. NCI-H460 cells were treated with various concentrations of α-tomatine (0, 0.5, 1, 1.5 μΜ) for 12 h, and nuclear extracts were analyzed by the EMSA for NF-κB and AP-1 DNA-binding activities. Figure 6a has shown a decrease in the DNA-binding activity of NF-κB. By contrast, AP-1 binding activity was not affected by α-tomatine. Further, the expressions of NF-κB, c-Fos, and c-Jun in nuclear extracts were analyzed by Western blotting to assess the possible inhibitory effect of α-tomatine. Figure 6b showed that the nuclear level of NF-κB (p50 and p65) was gradually diminished at doses of 0.5, 1, and 1.5 μM α-tomatine when compared to the 0 μM after treatment for 12 h. However, there was no noticeable change in the translocation of c-Fos and c-Jun under the same treatment condition. Also, the activation of NF-κB is through the phosphorylation of IκBα to release the NF-κB for nuclear translocation [35], and for binding to the promoter sites of target genes. To examine the effect of α-tomatine on IκBα regulation, we investigated whether α-tomatine has inhibitory effects on IκBα degradation and phosphorylation. As shown in Fig. 6c, α-tomatine blocked IκBα degradation through inhibiting phosphorylation of IκBα. Also, the intensity of Western blotting reflected that the α-tomatine at a concentration >0.5 μM could enhance IκBα protein expression.
α-Tomatine Suppresses the Levels of Phospho-38, MMP-2/9, u-PA and Invasion, Migration in Akt-Transfected NCI-H460 Cells
Our results had demonstrated that α-tomatine could suppress cell invasion/migration, down-regulate FAK/PI3K/Akt signal, and reduce MMP-7 expression in NCI-H460 cells. To further investigate whether the inhibition of α-tomatine was mainly through inhibition of FAK/PI3K/Akt signaling pathway, NCI-H460 cells were transiently transfected with active Akt. The Western blotting results showed that the cells expressed as a control vector indeed had diminished the levels of phospho-Akt and MMP-7 when cells were treated with α-tomatine (Fig. 7a). The expression of constitutively active Akt also improved the abilities of invasion and migration in NCI-H460 cells that were originally inhibited by α-tomatine as analyzed by Boyden chamber assay (Fig. 7b, c). After treatment with α-tomatine, the Akt phosphorylation, MMP-7 expression, and invasion/migration were decreased in the Akt-transfected NCI-H460 cells.
Discussion
Lung cancer is one of the most common malignancy, with a generally poor prognosis due to its tendency toward local invasion and subsequent metastasis. Recently, antimetastatic agents have been defined as a new class of cancer chemopreventive agent. α-Tomatine is a major glycoalkaloid compound of Lycopersicon esculentum Linn. Various studies have shown that α-tomatine exerts pleiotropic anticancer effects, preventive and anticarcinogenic as well as antiproliferative, in various in vivo and in vitro models. α-Tomatine is also reported to exhibit antibiotic activities against microorganisms (eg. Herpes simplex and Herpes zoster viruses) in human [36], to enhance the duration of action of anesthetics, which act by inhibiting acetylcholinesterase [37], and to potentiate the immune response of vaccines in mice [38].
To verify the anti-metastatic mechanism of α-tomatine on the invasion and migration of human NCI-H460 cells in vitro. We excluded the effect of NCI-H460 cells from tumor cells growth by MTT assay which is showing that the cell viability was significantly altered by treatment of α-tomatine at concentrations less than 1.5 μM. In addition, Flow cytometric analysis of NCI-H460 cells exposed to α-tomatine (at concentrations ranging from 2 to 4 μM) showed that α-tomatine exhibited an anti-proliferation effect. Previous studies reported that GSH depletion and direct oxidative damage are involved in the regulation cell growth and death. Therefore, the data from the analyses of mitochondrial membrane potential, intracellular ROS formation, and GSH content have demonstrated that cell growth was not affected by α-tomatine at a concentration less than 5.0 μM.
During cancer progression, some tumor cells become motile and gain the capacity to attack the host tissue leading to metastasis. FAK can be activated in response to diverse stimuli and plays an important role in the proliferation and metastasis of cells [39]. The overexpression and phosphorylation of FAK correlates with the increase of cell motility and invasion and alteration in the cytoskeleton [40]. Adhesion and spreading of cells on a variety of ECM proteins, including collagen type IV, leads to an increase in tyrosine phosphorylation and activation of FAK [41]. In melanoma cells, the increased expression of FAK correlates with increased cell motility [42]. Overexpression of FAK has also been reported in breast cancer and sarcoma [43, 44]. Also, FAK is at the crossroad of several signaling pathways, including PI3K/Akt and MAPKs pathways [45, 46]. Recent study showed that α-tomatine caused a dose-dependent decrease in cellular level of phospho-Akt, phospho-FAK, and PI3K. Nevertheless, there was no significant change in total and phosphorylated levels of MAPK at the same dosage. When NCI-H460 cells were treated with α-tomatine (0–1.5 μM) for 24 h, there were dramatically reduced the activity and expression of MMP-7, but not gelatinases of MMP isoforms (MMP-2 and MMP-9). It is of importance to note that MMP-7 plays roles in tumor progression, as over-expression of the MMP-7 gene in transgenic mice led to enhanced tumorigenesis in a breast cancer model [47]. Also, Sasaki et al. [48] reported that the survival rates of lung cancer patients were poor in those with an elevated MMP-7 mRNA expression on the tumor tissue. We have demonstrated that reduction of proteolytically active MMP-7 is involved in α-tomatine mediated-cell invasion and migration. In addition, the transcription of MMP-7 gene is regulated by upstream sequences, including motifs corresponding to NF-κB and AP-1 binding elements [16, 49]. Here, we have also found that α-tomatine inhibited MMP-7 expression through preventing IκBα being phosphorylated and enhancing IκBα protein expression, both leading to inactivation of NF-κB DNA-binding activity. A comprehensive analysis of MMP-7 expression in NCI-H460 cells will be necessary to fully understand the biological properties of NCI-H460 cells and to promote the development of new therapeutic strategies.
Owing to their roles in invasion and migration, Akt and MMP-7 were shown to be overexpressed in tumors with highly metastatic ability. NCI-H460 cells transfected with Akt1 cDNA (active form) showed an increase in phospho-Akt and also an increase in MMP-7 expression. This Akt activation resulted in an increase in invasion and migration as measured by a Boyden chamber assay. Furthermore, our genetic evidence revealed that FAK/PI3K/Akt signaling played a crucial role in α-tomatine-inhibited invasion/migration in this study. Owing to the activation of FAK/PI3K/Akt will stimulate cis-acting regulatory element including the binding site of NF-κB which play an important role in controlling MMP-7 gene expression in NCI-H460 cells.
To investigate and establish the lung antimetastatic model of α-tomatine in the future, we can utilize NCI-H460 cells-induced C57BL6 mice, and further investigate α-tomatine whether inhibits metastatic model of NCI-H460 cells in mice. Additional in vivo studies are needed to define (a) whether the observed effects of α-tomatine on lung metastasis (b) possible the molecular mechanism for the antimetastatic effect of α-tomatine.
In summary, we proposed a schematic presentation of possible mechanisms for the inhibitory effect of α-tomatine on invasion and migration of NCI-H460 cells (Fig. 8). These results imply the antimetastatic effect of the α-tomatine on NCI-H460 cells might be through inactivating PI3K/Akt signaling, as well as enhancing IκBα protein expression to reduce NF-κB DNA-binding activity, leading to the downregulation of MMP-7 expression. Besides, α-tomatine can interfere with the rearrangement of the actin cytoskeleton by decreasing the expression of p-FAK and contribute to the inhibition of cell invasion and migration. The α-tomatine could be further tested by in vivo model to justify if it is effective for prevention of lung cancer invasion or metastasis.
Abbreviations
- MMPs:
-
Matrix metalloproteinases
- ECM:
-
Extracellular matrix
- MAPK:
-
Mitogen-activated protein kinase
- ERK:
-
Extracellular signaling-regulating kinase
- JNK/SAPK:
-
c-Jun N-terminal kinase/stress-activated protein kinase
- PI3K:
-
Phosphoinositide 3-kinase
- NF-κb:
-
Nuclear factor kappa B
- AP-1:
-
Activator protein-1
- IκB:
-
Inhibitor of NF-κB
References
Greenlee, R. T., Hill-Harmon, M. B., Murraym, T., & Thunm, M. (2001). Cancer statistics, 2001. CA: A Cancer Journal for Clinicians, 51, 15–36.
Gupta, G. P., & Massague, J. (2006). Cancer metastasis: Building a framework. Cell, 127, 679–695.
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., et al. (2005). Cancer statistics, 2005. CA: A Cancer Journal for Clinicians, 55, 10–30.
Mitra, S. K., & Schlaepfer, D. D. (2006). Integrin-regulated FAK-Src signaling in normal and cancer cells. Current Opinion in Cell Biology, 18, 516–523.
Stupack, D. (2007). The biology of integrins. Oncology, 21, 6–12.
van Nimwegen, M. J., & van dewater, B. (2007). Focal adhesion kinase: A potential target in cancer therapy. Biochemical Pharmacology, 73, 597–609.
Filder, I. J. (2005). The organ microenvironment and cancer metastasis. Differentiation, 70, 498–505.
Shih, Y. W., Chen, P. S., Wu, C. H., Jeng, Y. F., & Wang, C. J. (2007). α-Chaconine-reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-κB in human lung adenocarcinoma A549 cells. Journal of Agriculture and Food Chemistry, 55, 11035–11043.
Khwaja, A. (1999). Akt is more than just a Bad kinase. Nature, 401, 33–34.
Chan-Hui, P. Y., & Weaver, R. (1998). Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades. The Biochemical Journal, 336, 599–609.
Trusolino, L., & Comoglio, P. M. (2002). Scatter-factor and semaphoring receptors: Cell signalling for invasive growth. Nature Reviews Cancer, 2, 289–300.
Chen, P. N., Hsieh, Y. S., Chiou, H. L., & Chu, S. C. (2005). Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chemico-Biological Interactions, 156, 141–150.
Kwon, G. T., Cho, H. J., Chung, W. Y., Park, K. K., Moon, A., & Park, J. H. (2009). Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. The Journal of Nutritional Biochemistry, 20, 663–676.
Lee, S. J., Park, S. S., Lee, U. S., Kim, W. J., & Moon, S. K. (2008). Signaling pathway for TNF-alpha-induced MMP-9 expression: Mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells. International Immunopharmacology, 8, 1821–1826.
Nagase, H., & Woessner, J. F., Jr. (1999). Matrix metalloproteinases. The Journal of Biological Chemistry, 274, 21491–21494.
Westermarck, J., & Kahari, V. M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. The FASEB Journal, 13, 781–792.
Viatour, P., Merville, M. P., Bours, V., & Chariot, A. (2005). Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends in Biochemical Sciences, 30, 43–52.
Karin, M., & Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annual Review of Immunology, 18, 621–663.
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Letters, 269, 199–225.
Lee, S. O., Jeong, Y. J., Im, H. G., Kim, C. H., Chang, Y. C., & Lee, I. S. (2007). Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochemical and Biophysical Research Communications, 354, 165–171.
Friedman, M., & Levin, C. E. (1995). α-Tomatine content in tomato and tomato products determined by HPLC with pulsed amperometric detection. Journal of Agriculture and Food Chemistry, 43, 1507–1511.
Lee, K. R., Kozukue, N., Han, J. S., Park, J. H., Chang, E. Y., Baek, E. J., et al. (2004). Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. Journal of Agriculture and Food Chemistry, 52, 2832–2839.
Morrow, W. J. W., Yang, Y. W., & Sheikh, N. A. (2004). Immunobiology of the tomatine adjuvant. Vaccine, 2004(22), 2380–2384.
Chiu, F. L., & Lin, J. K. (2008). Tomatidine inhibits iNOS and COX-2 through suppression of NF-κB and JNK pathways in LPS-stimulated mouse macrophages. FEBS Letters, 582, 2407–2412.
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55–63.
LeBel, C. P., Ischiopoulos, H., & Bondy, S. C. (1992). Evaluation of the probe 2,7-dichloro-fluorescin as indicator of reactive oxygen species formation and oxidative stress. Chemical Research in Toxicology, 5, 227–231.
Hisin, P. J., & Hilf, R. (1976). A fluorometric method for determination of oxidized and reduced glutathione in tissues. Analytical Biochemistry, 74, 214–226.
Ochi, Y., Atsumi, S., Aoyagi, T., & Umezawa, K. (1993). Inhibition of tumor cell invasion in the Boyden chamber assay by a mannosidase inhibitor, mannostatin A. Anticancer Research, 13, 1421–1424.
Chu, S. C., Chiou, H. L., Chen, P. N., Yang, S. F., & Hsieh, Y. S. (2004). Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Molecular Carcinogenesis, 40, 143–149.
Ito, H., Duxbury, M., Benoit, E., Clancy, T. E., Zinner, M. J., Ashley, S. W., et al. (2004). Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Research, 64, 7439–7446.
Ma, W., Lim, W., Gee, K., Aucoin, S., Nandan, D., Kozlowski, M., et al. (2001). The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide stimulated human macrophages. The Journal of biological chemistry, 276, 13664–13674.
Lin, H. H., Chen, J. H., Kuo, W. H., & Wang, C. J. (2007). Chemopreventive properties of Hibiscus sabdariffa L. on human gastric carcinoma cells through apoptosis induction and JNK/p38 MAPK signaling activation. Chemico-Biological Interactions, 165, 59–75.
Chandra, J., Samali, A., & Orrenius, S. (2000). Triggering and modulation of apoptosis by oxidative stress. Free Radical Biology and Medicine, 29, 323–333.
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003). Regulation of matrix metalloproteinases: An overview. Molecular and Cellular Biochemistry, 253, 269–285.
Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi, X., Lee, W. Y., et al. (1995). Coupling of a signal response domain in IκBa to multiple pathways for NF-kB activation. Molecular and Cellular Biology, 15, 2809–2818.
Chataing, B., Concepcion, J. L., de Cristancho, N. B., & Usubillaga, A. (1997). Estudio clinico de la efectividad de extractos alcaloides obtenidos de los frutos del Solanum americanum Miller sobre el Herpes simplex, Herpes Zoster y Herpes genitalis. Revista de la Facultad de Farmacia, 32, 18–25.
McGehee, D. S., Krasowski, M. D., Fung, D. L., Wilson, B., Gronert, G. A., & Moss, J. (2000). Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism. Anesthesiology, 93, 510–519.
Rajananthanan, P., Attard, G. S., Sheikhh, N., & Morrow, W. J. (2000). Novel aggregate structure modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice. Vaccine, 18, 140–152.
Parsons, J. T. (2003). Focal adhesion kinase: The first ten years. Journal of Cell Science, 116, 1409–1416.
Fujii, T., Koshikawa, K., Nomoto, S., Okochi, O., Kaneko, T., Inoue, S., et al. (2004). Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. Journal of Hepatology, 41, 104–111.
Mukhopadhyay, N. K., Gordon, G. J., Chen, C. J., Bueno, R., Sugarbaker, D. J., & Jaklitsch, M. T. (2005). Activation of focal adhesion kinase in human lung cancer cells involves multiple and potentially parallel signaling events. Journal of Cellular and Molecular Medicine, 9, 387–397.
Akasaka, T., van Leeuwen, R. L., Yoshinaga, I. G., Mihm, M. C., & Byers, H. H. (1995). Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. The Journal of Investigative Dermatology, 105, 104–108.
Owens, L. V., Xu, L., Craven, R. G., Dent, G. A., Weiner, T. M., Kornberg, L., et al. (1995). Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Research, 55, 2752–2755.
Weiner, T. M., Liu, E. T., Craven, R. J., & Cance, W. G. (1993). Expression of focal adhesion kinase gene and invasive cancer. Lancet, 342, 1024–1025.
Sonoda, Y., Watanabe, S., Matsumoto, Y., Aizu-Yokota, E., & Kasahara, T. (1999). FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. The Journal of Biological Chemistry, 274, 10566–10570.
Huang, C., Jacobson, K., & Schaller, M. D. (2004). MAP kinases and cell migration. Journal of Cell Science, 117, 4619–4628.
Rudolph-Owen, L. A., Chan, R., Muller, W. J., & Matrisian, L. M. (1998). The matrix metalloproteinase matrilysin influences early stage mammary tumorigenesis. Cancer Research, 58, 5500–5506.
Sasaki, H., Yukiue, H., Moiriyama, S., Kobayashi, Y., Nakashima, Y., Kaji, M., et al. (2001). Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. Journal of Surgical Research, 101, 242–247.
Aguirre Ghiso, J. A., Alonso, D. F., Farias, E. F., Gomez, D. E., & de Kier Joffe, E. B. (1999). Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. European Journal of Biochemistry, 263, 295–304.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shieh, JM., Cheng, TH., Shi, MD. et al. α-Tomatine Suppresses Invasion and Migration of Human Non-Small Cell Lung Cancer NCI-H460 Cells Through Inactivating FAK/PI3K/Akt Signaling Pathway and Reducing Binding Activity of NF-κB. Cell Biochem Biophys 60, 297–310 (2011). https://doi.org/10.1007/s12013-011-9152-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-011-9152-1